Sign in to fuzzto save your conversations, follow your research and come back anytime.

Company insights, generated from the most recent coverage.
Q1 FY27 net loss widened due to ₹1,910 Mn one-time Molycop acquisition costs and tax impact, despite revenue surge from consolidation.
Total expenses surged 254% YoY in Q2 FY26, with material costs up 283% and employee benefits up 146%, reflecting integration costs.
Molycop integration is structurally dilutive to margins; consolidated EBITDA expected at ~15% vs core consumables' 20-23%.
The Quarter story
The two most recent quarterly results, compared side-by-side.
Revenue and gross margins show steady improvement, though recent earnings face pressure from higher finance costs and a negative EPS swing.
Revenue from Operations grows from ₹3,560.9 Cr to ₹4,318.02 Cr from Q1 FY26 to Q1 FY27 — steady top-line expansion
EPS drops from ₹6.75 to -₹11.47 from Q2 FY26 to Q1 FY27 — recent earnings strain
Gross Profit Margin improves from 59% to 62% from Q1 FY26 to Q1 FY27 — better input cost control
Finance Cost rises from ₹50.93 Cr to ₹193.23 Cr from Q4 FY26 to Q1 FY27 — higher debt servicing burden
EBITDA recovers from ₹600 Cr to ₹954.77 Cr from Q3 FY26 to Q1 FY27 — resilient core profitability
Share of Profit of Joint Venture declines from ₹24.14 Cr to ₹9.28 Cr from Q2 FY26 to Q1 FY27 — weaker partner contribution
Cost of Material Consumed falls from ₹2,214.35 Cr to ₹1,536.06 Cr from Q4 FY26 to Q1 FY27 — eased material spending
PAT moderates from ₹1,092 Cr to ₹547 Cr from Q4 FY26 to Q1 FY27 — seasonal profit normalization